Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 32 holding rows worth $2,312,607,000.

Accession
0001144204-19-026372
Filed
2019-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 32 entries on the cover page, a total value of $2,312,607,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,312,607,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IMMUNOMEDICS INC452907108COM17,714,461$340,295,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM3,862,500$283,121,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR1,795,000$211,272,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW8,000,000$166,080,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,195,000$142,432,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM9,500,000$129,200,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS4,000,000$105,720,000thousands by filing date
ZOGENIX INC.98978L204Common Stock1,915,000$105,344,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR840,000$104,866,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM10,530,862$100,148,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM1,120,000$99,490,000thousands by filing date
TRICIDA INC89610F101COM1,700,000$65,654,000thousands by filing date
MYOKARDIA INC62857M105COM1,000,000$51,990,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM950,000$50,284,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock2,000,000$48,760,000thousands by filing date
MEDICINES CO584688105COM1,562,000$43,658,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM7,424,867$39,352,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock310,000$38,831,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM1,325,000$35,576,000thousands by filing date
ALLOGENE THERAPEUTICS INC019770106COM1,128,594$29,793,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock2,400,000$24,384,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS2,500,000$18,325,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM900,000$17,721,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock400,000$15,224,000thousands by filing date
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK475,000$11,419,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM725,000$9,628,000thousands by filing date
ALIMERA SCIENCES INC016259103COM6,240,000$6,614,000thousands by filing date
TELIGENT INC NEW87960W104COM5,231,206$6,068,000thousands by filing date
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK1,105,999$5,364,000thousands by filing date
KODIAK SCIENCES INC50015M109COM627,021$4,094,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH1,000,000$1,270,000thousands by filing dateput
OUTLOOK THERAPEUTICS INC69012T107COM84,999$630,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-19-026372this filing2019-05-15acceptance time not in the bulk data set